Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

INTRODUCTION: Survival rates in patients with non-medullary thyroid carcinoma (NMTC) are high, increasing the possibility to develop a second malignant neoplasm (SMN). Many studies investigated the relationship between increased risk of SMN in NMTC patients treated with radioiodine, but few data are...

Descripción completa

Detalles Bibliográficos
Autores principales: Capezzone, Marco, Sagnella, Alfonso, Cantara, Silvia, Fralassi, Noemi, Maino, Fabio, Forleo, Raffaella, Brilli, Lucia, Pilli, Tania, Cartocci, Alessandra, Castagna, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931333/
https://www.ncbi.nlm.nih.gov/pubmed/35311228
http://dx.doi.org/10.3389/fendo.2022.845954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931333/
https://www.ncbi.nlm.nih.gov/pubmed/35311228
http://dx.doi.org/10.3389/fendo.2022.845954

Ejemplares similares